<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-P6TN2YDH</identifier><date>2019</date><creator>Bošnjak, Maša</creator><creator>Čemažar, Maja</creator><creator>Serša, Gregor</creator><relation>documents/doc/P/URN_NBN_SI_doc-P6TN2YDH_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-P6TN2YDH_001.txt</relation><format format_type="issue">3</format><format format_type="volume">70</format><format format_type="type">article</format><format format_type="extent">str. 187-195</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">3309947</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-P6TN2YDH</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">chemotherapy</subject><subject language_type_id="eng">immune checkpoint inhibitors</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">radioterapija</subject><subject language_type_id="eng">radiotherapy</subject><subject language_type_id="slv">tarčno zdravljenje</subject><subject language_type_id="eng">targeted therapy</subject><subject language_type_id="slv">zaviralci imunskih kontrolnih točk</subject><title>Combining immune checkpoint inhibitors with chemotherapy, radiotherapy and targeted therapy</title><title>Kombinacija zaviralcev imunskih kontrolnih točk z radioterapijo, kemoterapijo in tarčnim zdravljenjem</title></Record>